Dynamic Capital Management’s GSK GSK Stock Holding History

Dynamic Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-40,410	Closed	-$2.18M	–	280
2017 Q2	$2.18M	Buy	+40,410	New	+$2.15M	0.49%	54
2017 Q1	–	Sell	-75,186	Closed	-$3.62M	–	335
2016 Q4	$3.62M	Buy	75,186 +47,087	+168%	+$2.33M	0.39%	77
2016 Q3	$1.51M	Buy	+28,099	New	+$1.54M	0.2%	168
2015 Q4	–	Sell	-7,040	Closed	-$338K	–	380
2015 Q3	$338K	Buy	+7,040	New	+$366K	0.09%	283
2015 Q1	–	Sell	-9,676	Closed	-$517K	–	292
2014 Q4	$517K	Sell	9,676 -18,384	-66%	-$1.03M	0.27%	104
2014 Q3	$1.61M	Sell	28,060 -7,768	-22%	-$476K	0.41%	78
2014 Q2	$2.4M	Buy	35,828 +28,788	+409%	+$1.95M	0.67%	24
2014 Q1	$470K	Buy	+7,040	New	+$476K	0.15%	226
2013 Q3	–	Sell	-7,280	Closed	-$455K	–	446
2013 Q2	$455K	Buy	+7,280	New	+$462K	0.12%	226

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Dynamic Capital Management's GSK Position: Q3 2017 in Review

Dynamic Capital Management sold out of GSK (GSK) in Q3 2017, closing a stake of 40,410 shares — an estimated $2.18M sold.

Dynamic Capital Management first reported a position in GSK in Q2 2013 and held it in 9 quarters. The position peaked at $3.62M in Q4 2016. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

Dynamic Capital Management reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
Dynamic Capital Management sold 40,410 GSK shares in Q3 2017, an estimated $2.18M.
Dynamic Capital Management first reported a position in GSK in Q2 2013 and held it in 9 quarters.
Dynamic Capital Management's GSK position peaked at $3.62M in Q4 2016.
741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Dynamic Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.